Electrosurgery devices use high-frequency electrical energy for cutting the bodies with utmost precision, lowest tissue damage, and oxygen sacrifice during an operation. It is used to generate electrical electrosurgery generators with a high-frequency electric current. Electrosurgical techniques are used in a lot of medical areas such as gynecology, urology, neurology, gastroenterology, abdominal surgery, overall operation, and others.
The electrosurgery devices market has been analyzed by utilizing the optimum combination of secondary sources and in-house methodology, along with an irreplaceable blend of primary insights. The real-time assessment of the market is an integral part of our market sizing and forecasting methodology. Our industry experts and panel of primary participants have helped in compiling relevant aspects with realistic parametric estimations for a comprehensive study.
In the 2020-2026 forecast period, the global electrosurgery market experiences a significant CAGR of 6.8% percent. This market growth can be due to technical advancements in electrosurgical instruments, as well as increasing medical, plastic, and cosmetic surgery.
Market drivers
By type of surgery
By product
o Bipolar Electrosurgical Instruments
▪ Advanced Vessel Sealing Instruments
▪ Bipolar Forceps
o Monopolar Electrosurgical Instruments
▪ Electrosurgical Pencils
▪ Electrosurgical Electrodes
▪ Suction Coagulators
▪ Monopolar Forceps
o Patient Return Electrodes
o Cords, Cables, and Adapters
o Others (Foot Switches, Carts, and Tip Cleaners)
By Geography
Key developments in this market
In May 2019, during Digestive Disease Week 2019, Olympus announced the release and approval of the ESG-150 Electrosurgery Generator (ESG-150). The ESG-150 electrosurgery generator provides steady output control, which automatically delivers the smallest efficient adapted energy production, allowing doctors to achieve good results in traditional GI and endoscopic pulmonary procedures. The introduction of a product has extended the company's product range and increased its market share.
In May 2018, Olympus announced the launch as well as the confirmation of the ESG-300 Electrosurgery Generator. Olympus' ESG-300 is a recent batch of electrosurgical systems designed exclusively for GI and pulmonary applications and includes all the methods and environments expected by physicians performing sophisticated medicinal procedures, many of which may include argon plasma coagulation (APC). The introduction of a product has extended the company's product range and increased its market share.
Competitor Analysis
This market is highly fragmented, and the key players have implemented various strategies such as agreements, new product launches, joint ventures, expansions, acquisitions, partnerships, and others to expand their reach in the industry. This report consists of market shares of the epigenetics diagnostic market for Europe, Asia Pacific, Middle East & Africa, North America, and South America.
Key Players in this market
A few major players in the global electrosurgery market are CONMED Corporation, Erbe Elektromedizin GmbH, Olympus Corporation, Smith & Nephew Plc, B. Braun Melsungen AG, Boston Scientific Corporation, Johnson & Johnson, Medtronic Plc, Bovie Medical Corporation, and BOWA-electronic GmbH & Co. KG among others
Insights provided by this report